# Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines

> **NCT03104075** · PHASE4 · COMPLETED · sponsor: **The Jackson Laboratory** · enrollment: 40 (actual)

## Conditions studied

- Pneumonia
- Aging

## Interventions

- **BIOLOGICAL:** Pneumococcal 13valent Conj Vaccine Diphtheria CRM197 Protein
- **BIOLOGICAL:** Pneumococcal Vaccine Polyvalent

## Key facts

- **NCT ID:** NCT03104075
- **Lead sponsor:** The Jackson Laboratory
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-17
- **Primary completion:** 2019-12-05
- **Final completion:** 2020-08-29
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03104075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03104075, "Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03104075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*